Gender-specific care of the patient with diabetes: Review and recommendations

American Diabetes Association, 2004, Clinical practice recommendations 2004: Introduction, Diabetes Care, 27, S1 Campaigne, 2000, Gender-specific health care in diabetes mellitus, J Gend Specif Med., 3, 51 Singh, 2001, Impact of gender on diabetes mellitus and its associated cardiovascular risk factors, J Gend Specif Med., 4, 28 Mosca, 2004, Evidence-based guidelines for cardiovascular disease prevention in women, J Am Coll Cardiol., 43, 900, 10.1016/j.jacc.2004.02.001 Nathan, 2003, Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus, N Engl J Med., 348, 2294, 10.1056/NEJMoa022314 Meinert, 1970, A study of the effects of hypoglycemic agents on vascular complications in patients with adultonset diabetes. II. Mortality results, Diabetes, 19, 789 Laakso, 1996, Glycemic control and the risk for coronary heart disease in patients with non-insulindependent diabetes mellitus: The Finnish studies, Ann Intern Med., 124, 127, 10.7326/0003-4819-124-1_Part_2-199601011-00009 Laakso, 1999, Hyperglycemia and cardiovascular disease in type 2 diabetes, Diabetes, 48, 937, 10.2337/diabetes.48.5.937 Gaede, 1999, Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study, Lancet, 353, 617, 10.1016/S0140-6736(98)07368-1 Shichiri, 2000, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21 Babaya, 2005, The stages of type lA diabetes, Ann N Y Acad Sci., 1051, 194, 10.1196/annals.1361.061 Apridonidze, 2005, Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome, J Clin Endocrlnol Metab., 90, 1929, 10.1210/jc.2004-1045 Rhodes, 2005, Type 2 diabetes-a matter of beta-cell life and death?, Science, 307, 380, 10.1126/science.1104345 Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343 Genuth, 2003, Follow up report on the diagnosis of diabetes mellitus, Diabetes Care, 26, 3160, 10.2337/diacare.26.11.3160 American Diabetes Association, 2005, Standards of medical care in diabetes, Diabetes Care, 28, S4, 10.2337/diacare.28.suppl_1.S4 Meigs, 2002, Fasting and the postchallenge glycemia and cardiovascu lar disease risk: The Framingham Offspring Study, Diabetes Care, 25, 1845, 10.2337/diacare.25.10.1845 Tesfaye, 2005, Vascular risk factors and diabetic neuropathy, N Engl J Med., 352, 341, 10.1056/NEJMoa032782 Witte, 2005, Risk factors for cardiac autonomic neu ropathy in type 1 diabetes mellitus, Diabetologia, 48, 164, 10.1007/s00125-004-1617-y Lehtinen, 1989, Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects, Diabetes, 38, 1307, 10.2337/diabetes.38.10.1307 Steel, 1987, Clinically apparent eating disorders in young diabetic women: Associations with painful neuropathy and other complications, BMJ (Clin Res Ed), 294, 859, 10.1136/bmj.294.6576.859 Seaquist, 1989, Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy, N Engl J Med., 320, 1161, 10.1056/NEJM198905043201801 Krolewski, 1988, Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus, N Engl J Med, 318, 140, 10.1056/NEJM198801213180303 Freire, 1998, Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM, Hypertension, 31, 896, 10.1161/01.HYP.31.4.896 1998, 16 Williams, 2002, Islet autoantibodies, nationality and gender: A multinational screening study in first-degree relatives of patients with type I diabetes, Diabetologia, 45, 217, 10.1007/s00125-001-0749-6 Gale, 2001, Diabetes and gender, Diabetologia, 44, 3, 10.1007/s001250051573 Mokdad, 2001, The continuing increase of diabetes in the US, Diabetes Care, 24, 412, 10.2337/diacare.24.2.412 Boyle, 2001, Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US, Diabetes Care, 24, 1936, 10.2337/diacare.24.11.1936 Centers for Disease Control. Statistics: 1999 Surveillance Report. Available at: http://www.cdc.gov/ diabetes/statistics/survl99/index.htm. Harvey, 2002, Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: Comparison of record linkage with capture-recapture analysis, J Epidemiol Community Health, 56, 18, 10.1136/jech.56.1.18 Cockram, 2000, The epidemiology of diabetes mellitus in the Asia-Pacific region, Hong Kong Med J, 6, 43 King, 1998, Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections, Diabetes Care, 21, 1414, 10.2337/diacare.21.9.1414 Yajnik, 2004, Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries, J Nutr, 134, 205, 10.1093/jn/134.1.205 Pradeepa, 2002, Epidemiology of diabetes in India-current perspective and future projections, J Indian Med Assoc, 100, 144 Pan, 1997, Prevalence of diabetes and its risk factors in China, 1994, Diabetes Care, 20, 1664, 10.2337/diacare.20.11.1664 Kaufman, 2005, Type 2 diabetes in children and youth, Endocrinol Metab Clin North Am, 34, 659, 10.1016/j.ecl.2005.04.010 Kaufman, 2005, Type 2 diabetes in children and youth, Endocrinol Metab Clin North Am, 34, ix, 10.1016/j.ecl.2005.04.010 Warram, 1990, Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents, Ann Intern Med, 113, 909, 10.7326/0003-4819-113-12-909 Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med, 350, 664, 10.1056/NEJMoa031314 Luft, 1993, Physiopathology of mitochondria. From Luft's disease to aging and diabetes, Lakartidningen, 90, 2770 Wisloff, 2005, Cardiovascular risk factors emerge after artificial selection for low aerobic capacity, Science, 307, 418, 10.1126/science.1108177 Hales, 1991, Fetal and infant growth and impaired glucose tolerance at age 64, BMJ, 303, 1019, 10.1136/bmj.303.6809.1019 Rich-Edwards, 1999, Birthweight and the risk for type 2 diabetes mellitus in adult women, Ann Intern Med, 130, 278, 10.7326/0003-4819-130-4_Part_1-199902160-00005 Forsen, 2000, The fetal and childhood growth of persons who develop type 2 diabetes, Ann Intern Med, 133, 176, 10.7326/0003-4819-133-3-200008010-00008 Eriksson, 2003, Early adiposity rebound in childhood and risk of type 2 diabetes in adult life, Diabetologia, 46, 190, 10.1007/s00125-002-1012-5 Bhargava, 2004, Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood, N Engl J Med, 350, 865, 10.1056/NEJMoa035698 Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab, 89, 2548, 10.1210/jc.2004-0395 Friedman, 2002, The function of leptin in nutrition, weight, and physiology, Nutr Rev, 60, S1, 10.1301/002966402320634878 Friedman, 2002, The function of leptin in nutrition, weight, and physiology, Nutr Rev, 60, S68, 10.1301/002966402320634878 Bergman, 2000, Free fatty acids and pathogenesis of type 2 diabetes mellitus, Trends Endocrinol Metab, 11, 351, 10.1016/S1043-2760(00)00323-4 Schwartz, 2005, Diabetes, obesity, and the brain, Science, 307, 375, 10.1126/science.1104344 Colditz, 1995, Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med, 122, 481, 10.7326/0003-4819-122-7-199504010-00001 Hu, 2004, Adiposity as compared with physical activity in predicting mortality among women, N Engl J Med., 351, 2694, 10.1056/NEJMoa042135 Villareal, 2004, Effect of DHEA on abdominal fat and insulin action in elderly women and men: A randomized controlled trial, JAMA, 292, 2243, 10.1001/jama.292.18.2243 NIH Consensus Development Panel on Physical Activity and Cardiovascular Health, 1996, Physical activity and cardiovascular health, JAMA, 276, 241, 10.1001/jama.1996.03540030075036 Hu, 2001, Physical activity and risk for cardiovascular events in diabetic women, Ann Intern Med, 134, 96, 10.7326/0003-4819-134-2-200101160-00009 Lee, 2001, Physical activity and coronary heart disease in women: Is “no pain, no gain” passe?, JAMA, 285, 1447, 10.1001/jama.285.11.1447 Gregg, 2003, JAMA, 289, 2379, 10.1001/jama.289.18.2379 Wei, 2000, Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes, Ann Intern Med, 132, 605, 10.7326/0003-4819-132-8-200004180-00002 Manson, 1991, A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women, Arch Intern Med, 151, 1141, 10.1001/archinte.1991.00400060077013 Juutilainen, 2004, Gender difference in the impact of type 2 diabetes on coronary heart disease risk, Diabetes Care, 27, 2898, 10.2337/diacare.27.12.2898 Abbott, 1988, The impact of diabetes on survival following myocardial infarction in men vs women: The Framingham Study, JAMA, 260, 3456, 10.1001/jama.1988.03410230074031 Hu, 2005, Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or with out history of myocardial infarction, Diabetologia, 48, 856, 10.1007/s00125-005-1730-6 Hu, 2003, Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes, Diabetologia, 46, 608, 10.1007/s00125-003-1096-6 Hu, 2005, The genderspecific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease, J Am Coll Cardiol, 45, 1413, 10.1016/j.jacc.2005.01.039 Juutilainen, 2005, Type 2 diabetes as a “coronary heart disease equivalent”: An 18-year prospective population-based study in Finnish subjects, Diabetes Care, 28, 2901, 10.2337/diacare.28.12.2901 Steinberg, 2000, Type II diabetes abrogates sex differences in endothelial function in premenopausal women, Circulation, 101, 2040, 10.1161/01.CIR.101.17.2040 Chan, 1995, Coagulation activation in type 2 diabetes mellitus: The higher coronary risk of female diabetic patients, Diabet Med, 12, 504, 10.1111/j.1464-5491.1995.tb00532.x Carr, 2001, Diabetes mellitus: A hypercoagulable state, J Diabetes Complications, 15, 44, 10.1016/S1056-8727(00)00132-X Gum, 2001, Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis, JAMA, 286, 1187, 10.1001/jama.286.10.1187 Hu, 2001, Diet, lifestyle, and the risk of type 2 diabetes mellitus in women, N Engl J Med, 345, 790, 10.1056/NEJMoa010492 Haapanen, 1997, Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women, Int J Epidemiol, 26, 739, 10.1093/ije/26.4.739 Manson, 1991, Physical activity and incidence of non-insulin-dependent diabetes mellitus in women, Lancet, 338, 774, 10.1016/0140-6736(91)90664-B Griffith, 1997, Depression in women with diabetes, Diabetes Spectrum, 10, 216 Anderson, 2001, The prevalence of comorbid depression in adults with diabetes: A meta-analysis, Diabetes Care, 24, 1069, 10.2337/diacare.24.6.1069 Goodnick, 1995, Treatment of depression in patients with diabetes mellitus, J Clin Psychiatry, 56, 128 Levine, 1997, Women, diabetes and disordered eating, Diabetes Spectrum, 10, 191 Rydall, 1997, Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus, N Engl J Med, 336, 1849, 10.1056/NEJM199706263362601 Ahmed, 1998, Pubertal growth in IDDM is determined by HbAlc levels, sex, and bone age, Diabetes Care, 21, 831, 10.2337/diacare.21.5.831 Mankhey, 2005, 17-Beta-estradiol replacement improves renal function and pathology associated with diabetic nephropathy, Am J Physiol Renal Physiol, 288, F399, 10.1152/ajprenal.00195.2004 Wells, 2005, Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the ex pression of renal estrogen receptors, Gend Med, 2, 227, 10.1016/S1550-8579(05)80052-X Hypertension in Diabetes Study (HDS), 1993, I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications, J Hypertens, 11, 309, 10.1097/00004872-199303000-00012 Grundy, 2002, Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association, Circulation, 105, 2231, 10.1161/01.CIR.0000013952.86046.DD Howard, 1998, Adverse effects of diabetes on multiple cardiovascular disease risk factors in women, Diabetes Care, 21, 1258, 10.2337/diacare.21.8.1258 Whitsel, 2000, Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: A meta-analysis, Diabetes Care, 23, 241, 10.2337/diacare.23.2.241 Olson, 2000, Coronary calcium in adults with type 1 diabetes: A stronger correlate of clinical coronary artery disease in men than in women, Diabetes, 49, 1571, 10.2337/diabetes.49.9.1571 Krakauer, 1995, Bone loss and bone turnover in diabetes, Diabetes, 44, 775, 10.2337/diabetes.44.7.775 Kumeda, 1998, Secondary osteoporosis and its treatment-diabetes mellitus, Nippon Rinsho, 56, 1579 van Daele, 1995, Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study, Ann Intern Med, 122, 409, 10.7326/0003-4819-122-6-199503150-00002 Koro, 2002, Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: Population based nested case-control study, BMJ, 325, 243, 10.1136/bmj.325.7358.243 Jin, 2002, Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases, Ann Clin Psychiatry, 14, 59, 10.3109/10401230209147399 Franks, 1995, Polycystic ovary syndrome, N Engl j Med, 333, 853, 10.1056/NEJM199509283331307 Dunaif, 1993, Insulin resistance and ovarian dysfunction, 301 Dunaif, 1996, The insulinsensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycys tic ovary syndrome, J Clin Endocrinol Metab, 81, 3299, 10.1210/jc.81.9.3299 Cooper, 2006, Major congenital malformations after firsttrimester exposure to ACE inhibitors, N Engl J Med, 354, 2443, 10.1056/NEJMoa055202 Briggs, 2002, Drug effects on the fetus and breastfed infant, Clin Obstet Gynecol, 45, 6, 10.1097/00003081-200203000-00004 Tabacova, 2003, Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment, Pharmacoepidemiol Drug Saf, 12, 633, 10.1002/pds.796 Clark, 1997, Gestational diabetes: Should it be added to the syndrome of insulin resistance?, Diabetes Care, 20, 867, 10.2337/diacare.20.5.867 de Veciana, 1995, Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy, N Engl J Med, 333, 1237, 10.1056/NEJM199511093331901 Dabelea, 1998, Increasing prevalence of type II diabetes in American Indian children, Diabetologia, 41, 904, 10.1007/s001250051006 Dabelea, 2000, Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: A study of discordant sibships, Diabetes, 49, 2208, 10.2337/diabetes.49.12.2208 Lunt, 1996, Women and diabetes, Diabet Med, 13, 1009, 10.1002/(SICI)1096-9136(199612)13:12<1009::AID-DIA281>3.0.CO;2-U Petersen, 1994, Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent dia betes mellitus, Am J Obstet Gynecol, 171, 400, 10.1016/S0002-9378(94)70041-9 Kaplan, 1998, Postmenopausal estrogens and risk of myocardial infarction in diabetic women, Diabetes Care, 21, 1117, 10.2337/diacare.21.7.1117 Andersson, 1997, Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeosta sis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab, 82, 638, 10.1210/jc.82.2.638 Manson, 1992, A prospective study of postmenopausal estrogen therapy and subsequent incidence of non insulin-dependent diabetes mellitus, Ann Epidemiol, 2, 665, 10.1016/1047-2797(92)90011-E Margolis, 2004, Effect of oestrogen plus progestin on the inci dence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormonal Trial, Diabetologia, 47, 1175, 10.1007/s00125-004-1448-x Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 138, 1, 10.7326/0003-4819-138-1-200301070-00005 Ferrara, 2001, Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry, Diabetes Care, 24, 1144, 10.2337/diacare.24.7.1144 Friday, 2001, Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes, J Clin Endocrinol Metab, 86, 48, 10.1210/jc.86.1.48 Barrett-Connor, 2004, Women and heart disease: The role of diabetes and hyperglycemia, Arch Intern Med, 164, 934, 10.1001/archinte.164.9.934 Kannel, 1995, Risk factors that attenuate the female coronary disease advantage, Arch Intern Med, 155, 57, 10.1001/archinte.1995.00430010063008 Roberts, 2004, Gender-specific aspects of the experience of coronary artery disease, Vol 1, 215 Hu, 2002, Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes, Diabetes Care, 25, 1129, 10.2337/diacare.25.7.1129 Fang, 2004, Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications, Endocr Rev, 25, 543, 10.1210/er.2003-0012 Gu, 1999, Diabetes and decline in heart disease mortality in US adults, JAMA, 281, 1291, 10.1001/jama.281.14.1291 Kaseta, 1999, Cardiovascular disease in the diabetic woman, J Clin Endocrinol Metab, 84, 1835, 10.1210/jc.84.6.1835 Kannel, 1979, Diabetes and cardiovascular risk factors: The Framingham Study, Circulation, 59, 8, 10.1161/01.CIR.59.1.8 Kanaya, 2002, Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: A meta-analysis, Arch Intern Med, 162, 1737, 10.1001/archinte.162.15.1737 Orchard, 1996, The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus, Ann Med, 28, 323, 10.3109/07853899608999089 Lee, 2000, Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies, Diabetes Care, 23, 962, 10.2337/diacare.23.7.962 Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic sub jects with and without prior myocardial infarction, N Engl J Med, 339, 229, 10.1056/NEJM199807233390404 Natarajan, 2003, Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease, Arch Intern Med, 163, 1735, 10.1001/archinte.163.14.1735 Gordon, 1989, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, 79, 8, 10.1161/01.CIR.79.1.8 Koerbel, 2003, Coronary heart disease in women with diabetes, Diabetes Spectrum, 16, 148, 10.2337/diaspect.16.3.148 The Diabetes Epidemiology Research International (DERI) Study, 1991, Sex differences in the mortality associated with insulin-dependent diabetes mellitus in four countries, Am J Epidemiol, 133, 577 Gregg, 2002, Diabetes and the incidence of function al disability in older women, Diabetes Care, 25, 61, 10.2337/diacare.25.1.61 Tavani, 2002, Diabetes mellitus as a contributor to the risk of acute myocardial infarction, J Clin Epidemiol, 55, 1082, 10.1016/S0895-4356(02)00486-9 Hu, 2001, The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 Years of follow-up, Arch Intern Med, 161, 1717, 10.1001/archinte.161.14.1717 Legato, 2000, Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: Implications for therapy, Am J Cardiol, 86, 15L, 10.1016/S0002-9149(00)01463-6 Mosca, 1997, Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association Writing Group, Circulation, 96, 2468, 10.1161/01.CIR.96.7.2468 Goldschmid, 1994, Dyslipidemia and ischemic heart disease mortality among men and women with diabetes, Circulation, 89, 991, 10.1161/01.CIR.89.3.991 UK Prospective Diabetes Study 27, 1997, Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex, Diabetes Care, 20, 1683, 10.2337/diacare.20.11.1683 Austin, 1998, Hypertriglyceridemia as a cardiovascular risk factor, Am J Cardiol, 81, 7B, 10.1016/S0002-9149(98)00031-9 Walden, 1984, Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations, N Engl J Med, 311, 953, 10.1056/NEJM198410113111505 Haffner, 1994, Greater effect of diabetes on LDL size in women than in men, Diabetes Care, 17, 1164, 10.2337/diacare.17.10.1164 Flegal, 1998, Overweight and obesity in the United States: Prevalence and trends, 1960–1994, Int J Obes Relat Metab Disord, 22, 39, 10.1038/sj.ijo.0800541 Manson, 1999, A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women, N Engl J Med, 341, 650, 10.1056/NEJM199908263410904 Bassuk, 2004, Gender and its impact on risk factors for cardiovascular disease, Vol 1, 193 Hanson, 1995, Rate of weight gain, weight fluctuation, and incidence of NIDDM, Diabetes, 44, 261, 10.2337/diabetes.44.3.261 Yudkin, 1999, C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?, Arterioscler Thromb Vasc Biol, 19, 972, 10.1161/01.ATV.19.4.972 Resnick, 2002, Diabetes and cardiovascular disease, Annu Rev Med, 53, 245, 10.1146/annurev.med.53.082901.103904 Franklin, 2002, Definition and epidemiology of hypertensive cardiovascular disease in women: The size of the problem, J Hypertens Suppl, 20, S3 Elveback, 1986, Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982, 61, 896 Glynn, 2002, Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure, Hypertension, 39, 105, 10.1161/hy1201.097199 Giugliano, 1996, Oxidative stress and diabetic vascular complications, Diabetes Care, 19, 257, 10.2337/diacare.19.3.257 Witztum, 1991, Role of oxidized low density lipoprotein in atherogenesis, J Clin Invest, 88, 1785, 10.1172/JCI115499 Marra, 2002, Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: A case for gender difference, Diabetes Care, 25, 370, 10.2337/diacare.25.2.370 Evans, 1994, Oxidized lipids in insulin-dependent diabetes mellitus: A sex-diabetes interaction?, Metabolism, 43, 1196, 10.1016/0026-0495(94)90065-5 Peiris, 1989, The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandro genic women, J Clin Endocrinol Metab, 68, 715, 10.1210/jcem-68-4-715 Newton, 2003, Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes, Diabetes Care, 26, 2810, 10.2337/diacare.26.10.2810 Barrett-Connor, 2003, Diabetes and heart disease, Diabetes Care, 26, 2947, 10.2337/diacare.26.10.2947 Giardina, 2000, Heart disease in women, Int J Fertil Womens Med, 45, 350 Steingart, 1991, Sex differences in the management of coronary artery disease, N Engl J Med, 325, 226, 10.1056/NEJM199107253250402 Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, JAMA, 280, 605, 10.1001/jama.280.7.605 Fonarow, 2001, Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the National Registry of Myocardial Infarction 3, Circulation, 103, 38, 10.1161/01.CIR.103.1.38 Wexler, 2005, Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes, Diabetes Care, 28, 514, 10.2337/diacare.28.3.514 Shekelle, 2003, Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials, J Am Coll Cardiol, 41, 1529, 10.1016/S0735-1097(03)00262-6 Walsh, 2004, Drug treatment of hyperlipidemia in women, JAMA, 291, 2243, 10.1001/jama.291.18.2243 Ridker, 2005, C-reactive protein levels and outcomes after statin therapy, N Engl J Med, 352, 20, 10.1056/NEJMoa042378 Nissen, 2005, Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease, N Engl J Med, 352, 29, 10.1056/NEJMoa042000 Graham, 2004, Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs, JAMA, 292, 2585, 10.1001/jama.292.21.2585 Ridker, 2003, C-reactive protein and risk of cardiovascular disease: Evidence and clinical application, Curr Atheroscler Rep, 5, 341, 10.1007/s11883-003-0004-3 Ehrenstein, 2005, Statins for atherosclerosis-as good as it gets?, N Engl J Med, 352, 73, 10.1056/NEJMe048326 Gilbert, 2004, Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting, Diabetes Care, 27, 990, 10.2337/diacare.27.4.990 Watanabe, 2001, Comparison of short-term outcomes following coronary artery stenting in men versus women, Am J Cardiol, 88, 848, 10.1016/S0002-9149(01)01890-2 Jacobs, 2002, Improved outcomes for women undergoing contemporary percutaneous coronary intervention: A report from the National Heart, Lung, and Blood Institute Dynamic registry, J Am Coll Cardiol, 39, 1608, 10.1016/S0735-1097(02)01835-1 Mehilli, 2003, Gender and restenosis after coronary artery stenting, Eur Heart J, 24, 1523, 10.1016/S0195-668X(03)00320-8 Moussa, 2004, Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRollmUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy, Circulation, 109, 2273, 10.1161/01.CIR.0000129767.45513.71 Flaherty, 2005, Diabetes and coronary revascularization, JAMA, 293, 1501, 10.1001/jama.293.12.1501 Furnary, 2003, Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting, J Thorac Cardiovasc Surg, 125, 1007, 10.1067/mtc.2003.181 Huang, 2001, The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus, Am J Med, 111, 633, 10.1016/S0002-9343(01)00978-0 Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187 Granger, 1993, Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents, J Am Coll Cardiol, 21, 920, 10.1016/0735-1097(93)90348-5 Hirsh, 2005, Insulin analogues, N Engl J Med, 352, 174, 10.1056/NEJMra040832 Buchbinder, 2002, Is the use of insulin lispro safe in pregnancy?, J Matern Fetal Neonatal Med, 11, 232, 10.1080/jmf.11.4.232.237 Garg, 2003, Insulin lispro therapy in pregnancies complicated by type 1 diabetes: Glycemic control and maternal and fetal outcomes, Endocr Pract, 9, 187, 10.4158/EP.9.3.187 van den Berghe, 2001, Intensive insulin therapy in the critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300 Song, 2004, Coronary heart disease risk assessment in diabetes mellitus: Comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications, Diabet Med, 21, 238, 10.1111/j.1464-5491.2004.01116.x Colagiuri, 2002, Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UK Prospective Diabetes Study 61, Diabetes Care, 25, 1410, 10.2337/diacare.25.8.1410 Saydah, 2004, Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes, JAMA, 291, 335, 10.1001/jama.291.3.335 Dahlof, 2002, Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol, Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3 Dornhorst, 1985, Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics with out alteration of insulin secretion, Lancet, 1, 123, 10.1016/S0140-6736(85)91900-2 Holzgreve, 2003, Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control, Am J Hypertens, 16, 381, 10.1016/S0895-7061(03)00062-1 Bakris, 2004, Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial, JAMA, 292, 2227, 10.1001/jama.292.18.2227 Villagra, 2004, Strategies to control costs and quality: A focus on outcomes research for disease management, Med Care, 42, 11124 Faxon, 2004, Improving qual ity of care through disease management: Principles and recommendations from the American Heart Association's Expert Panel on Disease Management, Circulation, 109, 2651, 10.1161/01.CIR.0000128373.90851.7B Sidorov, 2002, Diabetes Care, 25, 684, 10.2337/diacare.25.4.684 Department of Health and Human Services. Centers for Medicare & Medicaid Services, 2006 National Committee for Quality Assurance. Disease management accreditation & certification status list. Available at: http://www.ncqa. org/programs/accreditation/DM/dmaccredstatus.htm. Joint Commission on Accreditation of Healthcare Organizations, 2003 URAC. Disease management accreditation program overview. Available at: http://www.urac.org/prog-accred DM-po.asp?navid=accreditation pagename=prog-accred DM. Ridker, 2005, A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women, N Engl J Med, 352, 1293, 10.1056/NEJMoa050613 Grant, 2004, Trends in complexity of diabetes care in the United States from 1991 to 2000, Arch Intern Med, 164, 1134, 10.1001/archinte.164.10.1134 Rothman, 2004, Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program, JAMA, 292, 1711, 10.1001/jama.292.14.1711